312
Participants
Start Date
October 18, 2018
Primary Completion Date
April 12, 2019
Study Completion Date
April 12, 2019
Dulaglutide Pen
Injected on a practice pad.
Semaglutide Pen
Injected on a practice pad.
BRCR Medical Center, Inc., Camp Hill
Manassas Clinical Research Center, Manassas
Evidera, Bethesda
PI-Coor Clinical Research, LLC, Annandale
Carolina Research Center, Inc., Shelby
Georgia Clinical Research, Snellville
Palm Harbor Medical Associates, Palm Harbor
L-Marc Research Center, Louisville
Lillestol Research LLC, Fargo
Cedar-Crosse Research Center, Chicago
Juno Research, Houston
Juno Research, LLC, Houston
Long Beach Center for Clinical Research, Long Beach
Valley Research, Fresno
Eli Lilly and Company
INDUSTRY